|
|
|
Press Releases
MILESTONE SCIENTIFIC ANNOUNCES NOTICE OF ALLOWANCE FROM
US PATENT AND TRADEMARK OFFICE
Piscataway,
N.J. – (PR NEWSWIRE) – August 24, 2009 – Milestone
Scientific Inc. (OTCBB:MLSS), the recognized leader in advanced injection
technologies, today announced that the United States Patent and Trademark
Office has issued a Notice of Allowance for Milestone’s U.S.
patent application directed to the use of its disposable hand piece
for fluid administration. Milestone’s proprietary, award-winning
hand piece is an instrument currently utilized in conjunction with
the Company’s commercially available Computer-Controlled Local
Anesthetic Delivery (C-CLAD) systems, including the STA Single
Tooth Anesthesia System™, CompuDent® and CompuMed®.
Dr. Mark Hochman, Director of Clinical Affairs at Milestone Scientific,
noted, “We are very pleased with the U.S. Patent Office’s
decision to recognize the uniqueness of our invention. Moreover,
obtaining patent protection for this particular component of our C-CLAD
technology was an important step in further securing our position as
the industry leader in the delivery of subcutaneous drug delivery.”
A Notice of Allowance generally completes the substantive examination
of a patent application. The normal process which results in a
final issuance of a U.S. patent involves several administrative steps
that are typically completed in due course following the issuance of
such a Notice. To date, Milestone has been awarded a total of 21
U.S. utility and design patents relating to its C-CLAD technologies.
According to Leonard Osser, Milestone’s Chairman and Interim Chief
Executive Officer, “This Notice is a strong validation of Milestone’s
technological leadership and innovation, and demonstrates our team’s
proven ability to pioneer important new components and mechanisms that
add material value to our growing intellectual property platform.”
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged
in pioneering proprietary, highly innovative technological solutions
for the medical and dental markets. Central to the Company’s
IP platform and product development strategy is its patented CompuFlo® technology
for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is
a computer-controlled, pressure sensitive infusion, perfusion, suffusion
and aspiration technology, which provides real-time readouts of pressures,
fluid densities and flow rates, enabling the advanced delivery and
removal of a wide array of fluids. The STA Single
Tooth Anesthesia System™, a computer-controlled local anesthesia
delivery system, uses this technology to provide dentists with audible
and visual signals as to in-tissue pressure. Milestone’s
existing painless injection systems are currently sold in 25 countries. For
more information on these and other innovative Milestone products,
please visit the Company’s web site found at www.milestonescientific.com and www.STAis4U.com.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group
Dodi Handy, President and CEO
For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors, Elite
Media Group
407-585-1080 or via email at mlss@efcg.net
|
